Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Net Income: 2022-2025

Historic Net Income for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Net Income fell 152.45% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 74.51%. This contributed to the annual value of -$9.0 million for FY2024, which is 13.89% down from last year.
  • Per bioAffinity Technologies' latest filing, its Net Income stood at -$5.1 million for Q3 2025, which was down 24.39% from -$4.1 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Net Income peaked at -$88,052 during Q2 2022, and registered a low of -$5.1 million during Q3 2025.
  • For the 3-year period, bioAffinity Technologies' Net Income averaged around -$2.6 million, with its median value being -$2.3 million (2023).
  • Examining YoY changes over the last 5 years, bioAffinity Technologies' Net Income showed a top increase of 53.43% in 2023 and a maximum decrease of 1,876.30% in 2023.
  • bioAffinity Technologies' Net Income (Quarterly) stood at -$1.7 million in 2022, then plummeted by 41.72% to -$2.4 million in 2023, then decreased by 25.02% to -$3.0 million in 2024, then tumbled by 152.45% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.7 million during Q1 2025.